Literature DB >> 25234937

Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience.

Matthias Maruschke1, Diana Riebold, Martha Charlotte Holtfreter, Martina Sombetzki, Steffen Mitzner, Micha Loebermann, Emil Christian Reisinger, Oliver W Hakenberg.   

Abstract

BACKGROUND: The Pneumocystis pneumonia is an increasing problem in transplanted patients: up to 25% suffer from Pneumocystis pneumonia, occurring during the first 6 months after transplantation.
METHODS: From 2001 to 2009, we investigated 21 patients with pneumonia after renal transplantation for the presence of Pneumocystis jirovecii. The laboratory diagnosis was established by Grocott and Giemsa staining methods and Pneumocystis-specific mitochondrial transcribed large subunit nested polymerase chain reaction (PCR). The PCR was also used for the differentiation of Pneumocystis pneumonia from Pneumocystis carriage.
RESULTS: Of 21 patients, 7 had a Pneumocystis pneumonia, 6 were Pneumocystis carriers and 8 patients were negative. Four out of seven Pneumocystis pneumonia patients and two out of six patients with Pneumocystis carriage had a delayed graft function. An acute cytomegalovirus infection after transplantation was not detectable in the patients with Pneumocystis pneumonia, but in three patients with Pneumocystis carriage.
CONCLUSIONS: Pneumocystis pneumonia was present in 33.3% of transplanted patients with suspected pneumonia. An association between acute rejection or co-infections and Pneumocystis pneumonia or carriage in patients after renal transplantation cannot be excluded. In three out of seven Pneumocystis pneumonia patients, an overlapping of hospitalisation times and an onset of Pneumocystis pneumonia 6 months after transplantation was found. Thus, person-to-person transmission seems probable in these cases.

Entities:  

Mesh:

Year:  2014        PMID: 25234937     DOI: 10.1007/s00508-014-0608-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  40 in total

1.  Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice?

Authors:  Jennifer A McCaughan; Aisling E Courtney
Journal:  Nephrol Dial Transplant       Date:  2011-08-03       Impact factor: 5.992

2.  An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia.

Authors:  V Brunot; V Pernin; C Chartier; V Garrigue; F Vetromile; I Szwarc; S Delmas; P Portalès; D Basset; G Mourad
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

3.  Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients.

Authors:  Nicos Mitsides; Kerry Greenan; Darren Green; Rachel Middleton; Elizabeth Lamerton; Judith Allen; Jane Redshaw; Paul R Chadwick; Chinari Pk Subudhi; Grahame Wood
Journal:  Nephrology (Carlton)       Date:  2014-03       Impact factor: 2.506

4.  Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem.

Authors:  Peter V Coyle; Conall McCaughey; Aaron Nager; James McKenna; Hugh O'Neill; Susan A Feeney; Derek Fairley; Alison Watt; Ciara Cox; Tanya Curran
Journal:  J Med Microbiol       Date:  2012-04-19       Impact factor: 2.472

Review 5.  Pneumocystis jirovecii pneumonia in kidney transplantation.

Authors:  N Goto; S Oka
Journal:  Transpl Infect Dis       Date:  2011-10-31       Impact factor: 2.228

6.  Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.

Authors:  M Radisic; R Lattes; J F Chapman; M del Carmen Rial; O Guardia; F Seu; P Gutierrez; J Goldberg; D H Casadei
Journal:  Transpl Infect Dis       Date:  2003-06       Impact factor: 2.228

7.  A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.

Authors:  Shunsuke Mori; Isamu Cho; Mineharu Sugimoto
Journal:  J Rheumatol       Date:  2009-06-16       Impact factor: 4.666

8.  Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients.

Authors:  S M Arend; R G Westendorp; F P Kroon; J W van't Wout; J P Vandenbroucke; L A van Es; F J van der Woude
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

9.  Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient.

Authors:  Jordan Y Z Li; Tuck Y Yong; David I Grove; P Toby H Coates
Journal:  Clin Exp Nephrol       Date:  2008-08-30       Impact factor: 2.801

10.  Molecular evidence of Pneumocystis transmission in pediatric transplant unit.

Authors:  Britta Höcker; Constanze Wendt; Aimable Nahimana; Burkhard Tönshoff; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  1 in total

1.  A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?

Authors:  Mahdi Abastabar; Elham Mosayebi; Tahereh Shokohi; Mohammad T Hedayati; Mohammad R Jabari Amiri; Zahra Seifi; Iman Haghani; Masoud Aliyali; Sassan Saber; Maryam-Fatemeh Sheikholeslami
Journal:  Curr Med Mycol       Date:  2019-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.